Dermatomyositis

Last updated: November 01, 2022

Dermatomyositis

DMPR

DMPR

Chiari malformation
Syringomyelia
Ischemic stroke
Intracerebral hemorrhage
Epidural hematoma
Subarachnoid hemorrhage
Subdural hematoma
Arteriovenous malformation
Wernicke-Korsakoff syndrome
Broca aphasia
Wernicke aphasia
Concussion and traumatic brain injury
Seizures and epilepsy
Febrile seizure
Tension headache
Cluster headache
Migraine
Alzheimer disease
Vascular dementia
Dementia with Lewy bodies
Frontotemporal dementia
Normal pressure hydrocephalus
Creutzfeldt-Jakob disease
Parkinson disease
Huntington disease
Multiple sclerosis
Central pontine myelinolysis
Transverse myelitis
Acute disseminated encephalomyelitis
JC virus (Progressive multifocal leukoencephalopathy)
Adult brain tumors
Pituitary adenoma
Pediatric brain tumors
Acoustic neuroma (schwannoma)
Brain herniation
Brown-Sequard Syndrome
Cauda equina syndrome
Vitamin B12 deficiency
Friedreich ataxia
Treponema pallidum (Syphilis)
Meningitis
Sturge-Weber syndrome
Neurofibromatosis
Tuberous sclerosis
von Hippel-Lindau disease
Spinal muscular atrophy
Poliovirus
Charcot-Marie-Tooth disease
Guillain-Barre syndrome
Bell palsy
Carpal tunnel syndrome
Erb-Duchenne palsy
Myasthenia gravis
Lambert-Eaton myasthenic syndrome
Horner syndrome
Orthostatic hypotension
Congenital neurological disorders: Pathology review
Headaches: Pathology review
Seizures: Pathology review
Cerebral vascular disease: Pathology review
Traumatic brain injury: Pathology review
Spinal cord disorders: Pathology review
Dementia: Pathology review
Central nervous system infections: Pathology review
Movement disorders: Pathology review
Neuromuscular junction disorders: Pathology review
Demyelinating disorders: Pathology review
Adult brain tumors: Pathology review
Pediatric brain tumors: Pathology review
Neurocutaneous disorders: Pathology review
Hyperphosphatemia
Hypophosphatemia
Hyponatremia
Hypernatremia
Hypermagnesemia
Hypomagnesemia
Hypokalemia
Hyperkalemia
Hypercalcemia
Hypocalcemia
Renal tubular acidosis
Diabetic nephropathy
Lupus nephritis
Membranoproliferative glomerulonephritis
Membranous nephropathy
IgA nephropathy (NORD)
Renal tubular defects: Pathology review
Renal tubular acidosis: Pathology review
Acid-base disturbances: Pathology review
Electrolyte disturbances: Pathology review
Retinoblastoma
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Hemolytic-uremic syndrome
Antiphospholipid syndrome
Complement deficiency
Vitiligo
Albinism
Bone tumors
Osteochondroma
Chondrosarcoma
Osteomalacia and rickets
Paget disease of bone
Osteoporosis
Osteosclerosis
Muscular dystrophy
Polymyositis
Dermatomyositis
Inclusion body myopathy
Polymyalgia rheumatica
Sjogren syndrome
Rett syndrome

Transcript

Watch video only

In dermatomyositis, “-itis” refers to inflammation, “myos-“ to the muscles and “dermato-“ to the skin, so dermatomyositis is an inflammatory disorder which involves both the skin and the muscles.

Dermatomyositis is considered to be an autoimmune disease, meaning that the immune system has gone rogue and started attacking its own muscles and skin.

Okay, normally, the cells of the immune system are always hanging around, ready and excited to spot and fight against anything foreign that could cause harm inside the body.

B- lymphocytes produce antibodies against a specific part of these foreign pathogens, called antigen.

The tips of these antibodies strongly binds to this antigen, while the base of the antibody, called the constant region, gets recognized by complement proteins.

These complement proteins are a group of small proteins made by the liver that work together.

One complement protein cuts or cleaves the next one, activating it and creating an enzymatic cascade.

This process gets started with C1, the first of the complement proteins, which binds to the Fc, or the constant region of two antibody attached to the pathogen.

C1 then cleaves C2 and C4.

Portions of the C2 and C4 binds to the antigen and form an enzymatic complex that cleaves C3 into two portions, C3a and C3b.

C3b joins the enzymatic complex and then the complex is able to cleave C5 into two portions, C5a and C5b portion.

C5a and C3a float off into the blood where they attract other cells of the immune system to the affected area.

Meanwhile, C5b, C6, C7, C8 and multiple C9 proteins, come together on the surface of the pathogen to form the membrane attack complex or MAC.

The MAC attacks pathogenic cells, such as bacteria, by creating a channel in the cell membrane.

Because cells have more solutes in them than the outside environment, water flows into the cell by the process of osmosis, and that causes the cell to swell up and burst, which is called cell lysis.

In dermatomyositis, immune cells confuse normal muscle and skin proteins with foreign antigens.

This process is called molecular mimicry because from the perspective of the immune cells, a host protein is mimicking a foreign or tumor protein.

When normal proteins in our body trigger an immune response, that protein is called an autoantigen.

These autoantigens get picked up by B- lymphocytes, which begin producing antibodies against them.

In dermatomyositis, the autoantigens are usually found in various spots, like the endothelial cells lining the capillaries in muscle and skin cells, as well as soluble antigens coming from the nucleus or cytoplasm of destroyed muscle cells and skin cells.

So, in the first case, autoantibodies attach to the endothelial cells lining the capillaries near the perimysium, which is a sheath of connective tissue around bundles of muscle fibers.

Upon binding, these antibodies activate the complement cascade, leading to formation of the membrane attack complex which causes the endothelial cells to lyse.

The complement proteins also attract more inflammatory cells, like macrophages, to the area.

Key Takeaways

Dermatomyositis (DM) is a rare autoimmune disease that leads to inflammation and damage of the muscles and skin. It is associated with complement system activation, and autoantibodies like ANA, anti-Mi-2 and, anti-Jo-1 which result in proximal muscle weakness and photosensitive skin rashes. DM presents with muscle weakness, which often becomes worse over time, as well as a distinctive skin rash.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Clinical Immunology" Elsevier (2018)
  6. "Dermatomyositis" Clinics in Dermatology (2006)
  7. "Treatment of clinically amyopathic dermatomyositis in adults: a systematic review" British Journal of Dermatology (2016)
  8. "Treatment of clinically amyopathic dermatomyositis in adults: a systematic review" British Journal of Dermatology (2016)